United States
Germany
Japan
United Kingdom
China
SGLT1 (SLC5A1) (NM_000343) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC221312L1V
- LentiORF®
-
Lenti ORF particles, SLC5A1 (Myc-DDK tagged) - Human solute carrier family 5 (sodium/glucose cotransporter), member 1 (SLC5A1), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 11,400.00
货期*
详询
规格
| Cited in 1 publication. |
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | SGLT1 (SLC5A1) (NM_000343) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | D22S675; NAGT; SGLT1 |
| Vector | pLenti-C-Myc-DDK |
| ACCN | NM_000343 |
| ORF Size | 1992 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC221312).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_000343.1 |
| RefSeq Size | 2449 bp |
| RefSeq ORF | 1995 bp |
| Locus ID | 6523 |
| Domains | SSF |
| Protein Families | Druggable Genome, Transmembrane |
| MW | 73.3 kDa |
| Gene Summary | This gene encodes a member of the sodium-dependent glucose transporter (SGLT) family. The encoded integral membrane protein is the primary mediator of dietary glucose and galactose uptake from the intestinal lumen. Mutations in this gene have been associated with glucose-galactose malabsorption. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012] |
Citations (1)
| The use of this cDNA Clones has been cited in the following citations: |
|---|
|
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors
,Sipos, ?;Szennyes, E;Hajnal, N?;Kun, S;Szab?, KE;Uray, K;Soms?k, L;Docsa, T;Bokor, ?;,
Pharmaceuticals (Basel, Switzerland) 2021
,PubMed ID 33920838
[SLC5A1]
|
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
